Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Rydyznski Moderbacher, Carolyn, Ramirez, Sydney I., Dan, Jennifer M., Grifoni, Alba, Hastie, Kathryn M., Weiskopf, Daniela, Belanger, Simon, Abbott, Robert K. +16 more·2020·Cell

DOI 10.1016/j.cell.2020.09.038

Cited by (1,001)

Items 501–600 of 1,001

Age-related differences in immune dynamics during SARS-CoV-2 infection in rhesus macaques
Emily E. Speranza, Jyothi N. Purushotham, Julia Rebecca Port, Benjamin H. Schwarz, Meaghan Flagg, Brandi N. Williamson, Friederike Feldmann, Manmeet Singh, Lizzette Pérez-Pérez, Gail L. Sturdevant et al. · 2022 · Life Science Alliance
Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition
Thandeka Nkosi, Caroline Chasara, Anele Mbatha, Mza Nsimbi, Andrea Olga Papadopoulos, Tiza L Nguni, Farina Karim, Mohomed Yunus S Moosa, Inbal Gazy, Kondwani Jambo et al. · 2022 · eLife
Post-vaccination T cell immunity to omicron
Henning Jacobsen, Viviana Cobos Jiménez, Ioannis Sitaras, Naor Bar‐Zeev, Luka Čičin‐Šain, Melissa M. Higdon, Maria Deloria Knoll · 2022 · Frontiers in Immunology
SARS -CoV-2 T-cell immunity to variants of concern following vaccination
Kathleen Gallagher, Mark B. Leick, Rebecca C. Larson, Trisha R. Berger, Katelin Katsis, Jennifer Y. Yam, Gabrielle Brini, Korneel Grauwet, MGH COVID-19 Collection & Processing Team, Marcela Valderrama Maus · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Age-dependent immune profile in healthy individuals: an original study, systematic review and meta-analysis
Syuan-Ting Chang, Yi‐Fang Chuang, Ai‐Hsien Li, Yang‐Teng Fan, Man-Ru Liao, I‐Yu Chen, Ruo‐Wei Hung, TienYu Owen Yang, Yen‐Ling Chiu · 2024 · Immunity & Ageing
Mitochondrial dysfunction in acute and post-acute phases of COVID-19 and risk of non-communicable diseases
Helena Borland Madsen, Jon Ambæk Durhuus, Ove Andersen, Per thor Straten, Anne Rahbech, Claus Desler · 2024 · npj Metabolic Health and Disease
First‐in‐Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID‐19
Peter Chen, Gourab Datta, Ying Grace Li, Jenny Y. Chien, Karen Price, Emmanuel Chigutsa, Patricia Brown‐Augsburger, Josh Poorbaugh, Jeffrey A. Fill, Robert J. Benschop et al. · 2021 · Clinical Pharmacology & Therapeutics
Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection
Santosh Shenoy · 2021 · Inflammation Research
Immune-Guided Therapy of COVID-19
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, Linda Petrone, Fabrizio Cantini, Stefano Ugel, Stefania Canè, Vincenzo Bronte · 2022 · Cancer Immunology Research
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pedro J. Sánchez‐Cordón, David Astorgano, Joanna Luczkowiak, Rafael Bastos Delgado, José M. Casasnovas, Mariano Estéban, Juan García‐Arriaza · 2022 · Frontiers in Immunology
Persistence of Functional Memory B Cells Recognizing SARS-CoV-2 Variants Despite Loss of Specific IgG
Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, Heike Rübsamen, Ramona Gerhards, Celine Schneider, Paul R. Wratil, Marcel Stern, Peter Eichhorn, Oliver Till Keppler et al. · 2021 · iScience
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, Kristen M. Valentine, Paolla Beatriz Almeida Pinto, Andrew Gonzalez, José Ángel Regla-Nava, Erin Maule, Michael N. Nguyen, Norazizah Shafee et al. · 2024 · Nature Communications
Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis
Shaban Ahmad, Akash Pratap Singh, Nagmi Bano, Khalid Raza, Janmejay Singh, Guruprasad R. Medigeshi, Rajesh Pandey, Hemant Kumar Gautam · 2024 · International Journal of Biological Macromolecules
Role of antiviral CD8+ T cell immunity to SARS-CoV-2 infection and vaccination
Vivien Karl, Maike Hofmann, Robert Thimme · 2025 · Journal of Virology
Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection
Rohan Ameratunga, See‐Tarn Woon, Anthony Jordan, Hilary J Longhurst, Euphemia Yee Leung, Richard Henderson Steele, Klaus Lehnert, Russell G. Snell, Anna E. S. Brooks · 2021 · Expert Review of Clinical Immunology
Longitudinal analysis of antibody decay in convalescent COVID-19 patients
Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis · 2021 · Scientific Reports
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
Andreas Tolf, Anna Wiberg, Malin Müller, Faisal Hayat Nazir, Ivan Pavlović, Ida Laurén, Sara M. Mangsbo, Joachim Burman · 2022 · JAMA Network Open
CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, Tengchuan Jin · 2022 · Frontiers in Immunology
Immunosenescence is a therapeutic target for frailty in older adults: a narrative review
Huanan Jia, Wei Huang, Chuanfeng Liu, Shiyu Tang, Jing Zhang, Chongli Chen, Yuan Tian, Wen Zhong · 2022 · Annals of Translational Medicine
Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
Qiugang Zhu, Yan Xu, Ting Wang, Feiting Xie · 2022 · Frontiers in Immunology
High antibody levels and reduced cellular response in children up to one year after SARS-CoV-2 infection
Eva‐Maria Jacobsen, Dorit Fabricius, Magdalena Class, Fernando Topfstedt, Raquel Lorenzetti, Iga Janowska, Franziska Schmidt, Julian Staniek, Maria Zernickel, Thomas Stamminger et al. · 2022 · Nature Communications
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation
Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma, Savita Singh, Priyanka Sharma, Rucha Chandwaskar, Mudita Gosain, Sreevatsan Raghavan, Deepika Rathna Murugesan, Pallavi Kshetrapal et al. · 2024 · npj Vaccines
The role and uses of antibodies in COVID-19 infections: a living review
D. O. Scourfield, Sophie G. Reed, Max N. Quastel, Jennifer Alderson, Valentina M. T. Bart, Alicia Teijeira Crespo, Ruth Jones, Ellie Pring, F. Richter, Stephanie E. A. Burnell · 2021 · Oxford Open Immunology
Vaccination of cancer patients against COVID-19: towards the end of a dilemma
Avik Mandal, Pritanjali Singh, Arghadip Samaddar, Dharmendra Pratap Singh, Manika Verma, Amrita Rakesh, Rakesh Ranjan · 2021 · Medical Oncology
Effective chimeric antigen receptor T cells against SARS-CoV-2
Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, Horacio Uri Saragovi, Christopher E. Rudd · 2021 · iScience
Data-driven multi-scale mathematical modeling of SARS-CoV-2 infection reveals heterogeneity among COVID-19 patients
Shun Wang, Mengqian Hao, Zishu Pan, Jinzhi Lei, Xiufen Zou · 2021 · PLoS Computational Biology
Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients
Yuan Hou, Yadi Zhou, Michaela U. Gack, Yuan Luo, Lara Jehi, Timothy An-thy Chan, Haiyuan Yu, Charis Eng, Andrew A. Pieper, Feixiong Cheng · 2022 · Aging Cell
Exploring the Utility of NK Cells in COVID-19
Xuewen Deng, Hiroshi Terunuma, Mie Nieda · 2022 · Biomedicines
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model
Sara C. Johnston, Keersten Michelle Ricks, Inès Lakhal-Naouar, Alexandra N. Jay, Caroline Subra, Jo Lynne Raymond, Hannah A. D. King, Franco Rossi, Tamara L. Clements, David P. Fetterer et al. · 2022 · Vaccines
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Shobha Upreti, Mukesh Samant · 2022 · Pharmaceutical Research
The Role of Cellular Immunity in the Protective Efficacy of the SARS-CoV-2 Vaccines
Zhongjie Sun, Tingxin Wu, Huangfan Xie, Yuhuan Li, Jinlan Zhang, Xun‐Cheng Su, Hailong Qi · 2022 · Vaccines
Humoral and cellular immune responses to CoronaVac up to one year after vaccination
Priscilla R. Costa, Carolina Argondizo Correia, Mariana Prado Marmorato, Juliana Zanatta de Carvalho Dias, Mateus Vailant Thomazella, Amanda Cabral da Silva, Ana Carolina Soares de Oliveira, Arianne Fagotti Gusmão, Lílian Pereira Ferrari, Ângela Carvalho Freitas et al. · 2022 · Frontiers in Immunology
Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation
Oyebola O. Oyesola, Kerry L. Hilligan, Sivaranjani Namasivayam, Nina Howard, Chad S. Clancy, Mingming Zhao, Sandra D. Oland, Kasalina N. Kiwanuka, Nicole L. Garza, Bernard A. P. Lafont et al. · 2023 · Science Immunology
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, Dan Hameiri‐Bowen, Jakub T. Kopycinski, Bethany G. Charlton, Natasha Fisher-Pearson, Luke Muir, Annachiara Rosa, Chloë Roustan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
Eric D. Laing, Spencer L. Sterling, Stephanie A Richard, Nusrat J Epsi, Si’Ana A. Coggins, Emily C Samuels, Shreshta Phogat, Lianying Yan, Nicole Moreno, Christian L. Coles et al. · 2021 · medRxiv
Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development
Günl, Franziska, Mecate-Zambrano, Angeles, Rehländer, Selina, Hinse, Saskia, Ludwig, Stephan, Brunotte, Linda · 2021 · Vaccines
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
Johann Sellner, Paulus Stefan Rommer · 2021 · Vaccines
The presentation of SARS-CoV-2 peptides by the common HLA-A∗02:01 molecule
Christopher W. Szeto, Demetra S.M. Chatzileontiadou, Andrea Nguyen, Hannah Sloane, Christian A. Lobos, Dhilshan Jayasinghe, Hanim Halim, Corey Smith, Alan Riboldi‐Tunnicliffe, Emma J. Grant et al. · 2021 · iScience
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity
Alexander A. Lehmann, Greg A. Kirchenbaum, Ting Zhang, Pedro Antonio Reche, Paul Lehmann · 2021 · Frontiers in Immunology
Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
Elisa Petruccioli, Saeid Najafi Fard, Assunta Navarra, Linda Petrone, Valentina Vanini, Gilda Cuzzi, Gina Gualano, Luca Pierelli, Antonio Bertoletti, Emanuele Nicastri et al. · 2021 · Journal of Translational Medicine
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects
Eleonora Gallerani, Davide Proietto, Beatrice Dallan, Marco Campagnaro, Salvatore Pacifico, Valentina Albanese, Erika Marzola, Peggy Marconi, Antonella Caputo, Victor Appay et al. · 2021 · Frontiers in Immunology
A functional assay for serum detection of antibodies against SARS‐CoV‐2 nucleoprotein
Anna Albecka, Dean Clift, Marina Vaysburd, Tyler Rhinesmith, Sarah Caddy, David Mordechai Favara, Helen Baxendale, Leo C. James · 2021 · The EMBO Journal
Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine
Jie Bai, Asako Chiba, Goh Murayama, Taiga Kuga, Naoto Tamura, Sachiko Miyake · 2022 · Frontiers in Immunology
Hallmarks of Severe COVID-19 Pathogenesis: A Pas de Deux Between Viral and Host Factors
Roberta Rovito, Matteo Augello, Assaf Ben-Haim, Valeria Bono, Antonella d’Arminio Monforte, Giulia Carla Marchetti · 2022 · Frontiers in Immunology
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response
Jernej Pušnik, Julia König, Karola Mai, Enrico Richter, Jasmin Zorn, Hannah Proksch, Bianca Schulte, Galit Alter, Hendrik Streeck · 2022 · Journal of Virology
Upregulation of PD-1 Expression and High sPD-L1 Levels Associated with COVID-19 Severity
Danielle Rosa Beserra, Ricardo Wesley Alberca, Anna Cláudia Calvielli Castelo Branco, Luana de Mendonça Oliveira, Milena Mary de Souza Andrade, Sarah Cristina Gozzi-Silva, Franciane Mouradian Emidio Teixeira, Tatiana Mina Yendo, Alberto José da Silva Duarte, Maria Notomi Sato · 2022 · Journal of Immunology Research
Immune Determinants of Viral Clearance in Hospitalised COVID-19 Patients: Reduced Circulating Naïve CD4+ T Cell Counts Correspond with Delayed Viral Clearance
Mihaela Zlei, Igor A. Sidorov, Simone A. Joosten, Mirjam H.M. Heemskerk, Sebenzile K. Myeni, Cilia R. Pothast, Caroline S. van der Blij-de Brouwer, A.Linda van der Zanden, Krista E. van Meijgaarden, Shessy Torres Morales et al. · 2022 · Cells
Dynamic activity in cis-regulatory elements of leukocytes identifies transcription factor activation and stratifies COVID-19 severity in ICU patients
Michael T. Y. Lam, Sascha H. C. Duttke, Mazen Faris Odish, Hiep Dinh Le, Emily A. Hansen, Celina T. Nguyen, Samantha Trescott, Roy Y. Kim, Shaunak Deota, Max W. Chang et al. · 2023 · Cell Reports Medicine
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
Chris Ka Pun Mok, Chunke Chen, Shilin Zhao, Yuanxin Sun, Karen K. L. Yiu, Tat‐On Chan, Ho-Lun Lai, Kiu Cheung Lai, Ka Man Lau, Kwun Cheung Ling et al. · 2023 · The Lancet Microbe
SARS-CoV-2 and the host-immune response
David P. Maison, Youping Deng, Mariana Gerschenson · 2023 · Frontiers in Immunology
The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems
Maryam Golzardi, Altijana Hromić‐Jahjefendić, Jasmin Šutković, Orkun Aydın, Pınar Ünal‐Aydın, Tea Bećirević, Elrashdy M Moustafa Mohamed Redwan, Alberto Rubio‐Casillas, Vladimir Nikolaevich Uversky · 2024 · Biomedicines
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Holden Terry Maecker · 2021 · Journal for ImmunoTherapy of Cancer
MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19
Matthaios G. Speletas, Katerina Dadouli, Argyro Syrakouli, Nikolaos Gatselis, Georgios S. Germanidis, Varvara Α. Mouchtouri, Ioannis Koulas, Anna Samakidou, Anastasia Nikolaidou, Aggelos Stefos et al. · 2021 · Immunobiology
A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters
Phanramphoei Namprachan Frantz, Aleksandr Barinov, Claude Ruffié, Chantal Combredet, Valérie Najburg, Guilherme Dias de Melo, Florence Larrous, Lauriane Kergoat, Samaporn Teeravechyan, Anan Jongkaewwattana et al. · 2021 · Nature Communications
T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future Variants
Thi H. O. Nguyen, Carolyn A. Cohen, Louise C. Rowntree, Maireid B. Bull, Asmaa Hachim, Katherine Kedzierska, Sophie A. Valkenburg · 2021 · Frontiers in Medicine
Telomere-length dependent T-cell clonal expansion: A model linking ageing to COVID-19 T-cell lymphopenia and mortality
James Jay Anderson, Ezra Susser, Konstantin G. Arbeev, Anatoliy I. Yashin, Daniel A Levy, Simon Verhulst, Abraham Aviv · 2022 · EBioMedicine
Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
Flavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, Patrizia Leone, Massimo Spada, Antonio Di Virgilio, Andrea Giovannelli, Massimo Sanchez, Andrea Cara, Zuleika Michelini et al. · 2022 · Viruses
Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab
Barbora Bačová, Zuzana Kohutová, Ivana Karlova Zubata, Ľubica Gahérová, Petr Kučera, Tomáš Heizer, Marcela Mikesova, Tomáš Karel, Jan Novák · 2022 · Clinical and Experimental Medicine
T Cell Epitope Discovery in the Context of Distinct and Unique Indigenous HLA Profiles
Luca Hensen, Patricia T. Illing, Louise C. Rowntree, Jane Davies, Adrian Miller, Steven Y. C. Tong, Jennifer R. Habel, Carolien E. van de Sandt, Katie L. Flanagan, Anthony Wayne Purcell et al. · 2022 · Frontiers in Immunology
Inducing broad-based immunity against viruses with pandemic potential
Alessandro Sette, Erica Ollmann Saphire · 2022 · Immunity
Chemokines, soluble PD-L1, and immune cell hyporesponsiveness are distinct features of SARS-CoV-2 critical illness
Eric D. Morrell, Pavan K. Bhatraju, Neha Alhad Sathe, Jonathan J. Lawson, L. Mabrey, Sarah E. Holton, Scott Presnell, ALICE E. WIEDEMAN, Carolina Acosta‐Vega, Mallorie A. Mitchem et al. · 2022 · American Journal of Physiology-Lung Cellular and Molecular Physiology
Immunization With Lipopolysaccharide-Activated Dendritic Cells Generates a Specific CD8+ T Cell Response That Confers Partial Protection Against Infection With Trypanosoma cruzi
Lucía Biscari, Cintia Daniela Kaufman, Cecilia Farré, Victoria Huhn, María Florencia Pacini, Camila Bulfoni Balbi, Karina A. Gómez, Ana Rosa Pérez, Andrés Alloatti · 2022 · Frontiers in Cellular and Infection Microbiology
Local and Systemic Immunity Are Impaired in End-Stage-Renal-Disease Patients Treated With Hemodialysis, Peritoneal Dialysis and Kidney Transplant Recipients Immunized With BNT162b2 Pfizer-BioNTech SARS-CoV-2 Vaccine
Magdalena Piotrowska, Maciej Zieliński, Leszek Tylicki, Bogdan Biedunkiewicz, Alicja Kubanek, Zuzanna Ślizień, Karolina Polewska, Piotr Tylicki, Marta Muchlado, Justyna Sakowska et al. · 2022 · Frontiers in Immunology
Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination
Nungruthai Suntronwong, Sitthichai Kanokudom, Chompoonut Auphimai, Suvichada Assawakosri, Thanunrat Thongmee, Preeyaporn Vichaiwattana, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Jira Chansaenroj et al. · 2022 · Journal of Medical Virology
From Alpha to omicron: The response of T cells
Alba Grifoni, Alessandro Sette · 2022 · Current Research in Immunology
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, Zuyong Zhang · 2022 · iScience
Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus
Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Yogendra Shantaram Padwad, Vipin K. Hallan, Sanjay Kumar · 2022 · Pharmacological Reports
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Spyridoula Vasileiou, LaQuisa Chimere Hill, Manik Kuvalekar, Aster G. Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini D. Lulla, Kimberly Mooney, Natalia Lapteva, Bambi Grilley et al. · 2022 · Haematologica
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
Yun Shan Goh, Angéline Rouers, Siew‐Wai Fong, Nicole Ziyi Zhuo, Pei Xiang Hor, Chiew Yee Loh, Yu‐Ling Huang, Vanessa Kexin Neo, Isaac Kai Jie Kam, Bei Wang et al. · 2022 · Frontiers in Immunology
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Francis R. Hopkins, Melissa Govender, Cecilia Svanberg, Johan Nordgren, Hjalmar Waller, Åsa Nilsdotter‐Augustinsson, Anna Jonsson Henningsson, Marie Hagbom, Johanna Sjöwall, Sofia N. Nyström et al. · 2023 · Frontiers in Immunology
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Singh, Sudeep Kumar · 2023 · Vaccines
DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
Joel N. Maslow, Ijoo Kwon, Sagar B. Kudchodkar, Deborah Kane, Amha Tadesse, Hyojin Lee, Young K. Park, Kar Muthumani, Christine C. Roberts · 2023 · Vaccines
Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
Xiaoli Zhuang, Yu Jiang, Xiaofang Yang, Lin Fu, Lan Luo, Ziyuan Dong, Ju Zhao, Feilong Hei · 2023 · Frontiers in Immunology
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
Ranjan K. Mohapatra, Nahed Ahmed El-Shall, Ruchi Tiwari, Firzan Nainu, Venkataramana Kandi, Ashish Kumar Sarangi, Teroj Abdulrahman Mohammed, Perumal Arumugam Desingu, Chiranjib Chakraborty, Kuldeep Dhama · 2022 · Human Vaccines & Immunotherapeutics
Occupational Exposure in the Lombardy Region (Italy) to SARS-CoV-2 Infection: Results from the MUSTANG–OCCUPATION–COVID-19 Study
Paola Della Valle, Marco Fabbri, Fabiana Madotto, Pietro Ferrara, Paolo Cozzolino, Elisabetta Calabretto, Marco Italo D'Orso, Ermanno Longhi, Riccardo Polosa, Michele Augusto Riva et al. · 2021 · International Journal of Environmental Research and Public Health
COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
Joowon Yim, Hee Hyun Lim, Youngjoo Kwon · 2021 · Archives of Pharmacal Research
Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients
Jennifer M. Sasson, Joseph J. Campo, Rebecca M. Carpenter, Mary K. Young, Arlo Z. Randall, Krista Trappl, Amit Oberai, Christopher Hung, Joshua M. Edgar, Andy Teng et al. · 2021 · mBio
Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
Dana Rose Julian, Megan A. Kazakoff, Akhil Patel, Jesse M. Jaynes, Monte S. Willis, Cecelia Chrsitina Yates · 2021 · Current Pathobiology Reports
Plant-Based Vaccines in Combat against Coronavirus Diseases
Benita Ortega-Berlanga, Tomasz Pniewski · 2022 · Vaccines
In-depth analysis of SARS-CoV-2–specific T cells reveals diverse differentiation hierarchies in vaccinated individuals
Li Li, Muharrem Müftüoğlu, Shaoheng Liang, Mahesh Basyal, Jiangxing Lv, Mehmet Emin Akdogan, Ken Chen, Michael Andreeff, Christopher R. Flowers, Simrit Parmar · 2022 · JCI Insight
Cellular and Humoral Immunity to SARS‐CoV‐2 Infection in Multiple Sclerosis Patients on Ocrelizumab and Other Disease‐Modifying Therapies: A Multi‐Ethnic Observational Study
Ilya Kister, Y. Patskovsky, Ryan Curtin, Jinglan Pei, Katherine Perdomo, Zoe Rimler, Iryna Voloshyna, Marie I. Samanovic, Amber R. Cornelius, Yogambigai Velmurugu et al. · 2022 · Annals of Neurology
Effectiveness and safety of SARS‐CoV‐2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta‐analysis and meta‐regression
Abhishek Bhurwal, Hemant Raj Mutneja, Vikas Bansal, Akshay Goel, Shilpa Khanna Arora, Bashar M. Attar, Carlos D. Minacapelli, Gursimran Singh Kochhar, Lea Ann Chen, Steven R. Brant et al. · 2022 · Alimentary Pharmacology & Therapeutics
PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease
Maite Duhalde Vega, Daniela Olivera, Gustavo Gastão Davanzo, Mauricio Bertullo, Verónica Noya, Gabriela Fabiano de Souza, Stéfanie Primon Muraro, Ícaro Maia Santos de Castro, Ana Paula Arévalo, Martina Crispo et al. · 2022 · Science Advances
A novel vaccine based on SARS-CoV-2 CD4+ and CD8+ T cell conserved epitopes from variants Alpha to Omicron
Iam Palatnik de Sousa, Zachary S. Wallace, Stephany Christiny Cavalcante, Maria Paula Fonseca Ribeiro, João Antônio Barbosa Martins Silva, Rafael Ciro Marques Cavalcante, Richard H. Scheuermann, M Palatnik · 2022 · Scientific Reports
Association between SARS-CoV-2 RNAemia and dysregulated immune response in acutely ill hospitalized COVID-19 patients
Roberta Rovito, Valeria Bono, Matteo Augello, Camilla Tincati, Federica Mainoldi, Guillaume Beaudoin-Bussières, Alexandra Tauzin, Silvia Bianchi, Mohamad Hadla, Vaibhav Yellenki et al. · 2022 · Scientific Reports
Current understanding of T cell immunity against SARS-CoV-2
Xiuyuan Lu, Sho Yamasaki · 2022 · Inflammation and Regeneration
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial
Ikram Din Ujjan, Saeed Khan, Roohi Nigar, Hammad Ahmed, Sagheer Ahmad, Amjad P. Khan · 2023 · Frontiers in Nutrition
Antigen‐specific and cross‐reactive T cells in protection and disease
Ning Jenny Jiang, Michael D. Malone, Shahab Chizari · 2023 · Immunological Reviews
Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Peng Pi, Zhipeng Zeng, Liqing Zeng, Bing Han, Xizhe Bai, Shousheng Xu · 2023 · Frontiers in Pharmacology
Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects
Shanhe Yu, Caixia Di, Shijun Chen, Mingquan Guo, Jiayang Yan, Zhaoqin Zhu, Li Liu, Ruixue Feng, Yinyin Xie, Ruihong Zhang et al. · 2021 · Cell Research
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Lindsay N. Carpp, Ollivier Hyrien, Youyi Fong, David C. Benkeser, Sanne Roels, Daniel J Stieh, Ilse Van Dromme, Griet A. Van Roey, Avi Kenny, Ying Huang et al. · 2024 · Nature Communications
COVID-19: the new challenge for rheumatologists. One year later
Ilaria Puxeddu, Francesco Ferro, Elena Bartoloni, Elena Elefante, Chiara Baldini, Carlo Alberto Scirè, Rosaria Talarico, Paola Migliorini, Marta Mosca, Stefano Bombardieri · 2021 · Clinical and Experimental Rheumatology
Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
Alessio Mazzoni, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, Lorenzo Salvati, Seble Tekle Kiros, Roberto Semeraro, Luca Pengue, Maria Grazia Colao et al. · 2021 · Clinical & Translational Immunology
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men
Nina Le Bert, Wan Ni Chia, Wei Yee Wan, Alvin Kuo Jing Teo, Samuel Zeng Rong Chong, Nicole Tan, Doreen Soek Chin Tan, Adeline Chia, Iain Beehuat Tan, Kamini Kunasegaran et al. · 2021 · Emerging Microbes & Infections
Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults
Sloan A. Lewis, Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Izabela Coimbra Ibraim, Amanda N. Pinski, Nicholas S. Rhoades, Micaila Curtis, Xiwen Jiang et al. · 2021 · Nature Aging
Immunoinformatics Analysis of SARS-CoV-2 ORF1ab Polyproteins to Identify Promiscuous and Highly Conserved T-Cell Epitopes to Formulate Vaccine for Indonesia and the World Population
Marsia Gustiananda, Bobby Prabowo Sulistyo, David Agustriawan, Sita Andarini · 2021 · Vaccines
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis
Qi Chen, Kongxin Zhu, Xiaohui Liu, Chunlan Zhuang, Xingcheng Huang, Yue Huang, Xingmei Yao, Jiali Quan, Hongyan Lin, Shoujie Huang et al. · 2022 · Emerging Microbes & Infections
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
Jacob Pitcovski, Nady Gruzdev, Anna Abzach, Chen Katz, Ran Ben‐Adiva, Michal Brand Shwartz, Itamar Yadid, Einav Ratzon-Ashkenazi, Ken Emquies, Hadasa Israeli et al. · 2022 · Vaccine
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
Maria De Santis, Francesca Motta, Natasa Isailovic, Massimo Clementi, Elena Criscuolo, Nicola Clementi, Antonio Tonutti, Stefano Rodolfi, Elisa Barone, Francesca Colapietro et al. · 2022 · Vaccines
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Claire Mullender, Kelly da Costa, Aljawharah Alrubayyi, Sarah Lilian Pett, Dimitra Peppa · 2022 · Oxford Open Immunology